Longeveron (LGVN) Current Deferred Revenue (2021 - 2026)
Longeveron's Current Deferred Revenue came in at $40,000 for Q2 2026, unchanged from $40,000 a year earlier and down 60.8% from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Going back to Q4 2021, Longeveron's Current Deferred Revenue data covers 16 quarters.
- Current Deferred Revenue carries a four-year compound annual growth rate of -33.0% (FY2021 to FY2025).
- Going back by year, Current Deferred Revenue was $40,000 in FY2024 (-92.1%), $506,000 in FY2023 (unchanged), $506,000 in FY2022 (+154.3%) and $199,000 in FY2021.
- The five-year range for quarterly Current Deferred Revenue is $40,000 (Q4 2024) to $826,000 (Q1 2024).
- Year-over-year, Current Deferred Revenue increased in 1 of the last eight quarters, with an average decline of 48.3%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q4 2022 (growth of 154.3%), and the weakest in Q4 2024 (a decline of 92.1%).
- Business Quant data shows LGVN's Current Deferred Revenue at $102,000 (Q1 2026), $40,000 (Q4 2025) and $40,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Longeveron | 8.14 Mn | -31.66 Mn | 182,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 826,000.00 |
| Dec 31, 2023 | 506,000.00 |
| Sep 30, 2023 | 506,000.00 |
| Jun 30, 2023 | 496,000.00 |
| Mar 31, 2023 | 556,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Dec 31, 2021 | 199,000.00 |
API Access
Longeveron Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();